Supplement evidence

025 / 575Fiber

Psyllium / soluble fiber

View my plan →

The short answer

Improving constipation and modestly lowering LDL cholesterol when taken consistently with water.

Evidence and scope: Supported for specific outcomes
This status does not grade the ingredient for every goal, outcome, or person.
Important limitation: Clinical endpoints and lifespan effects cannot be inferred from LDL or bowel changes alone.
Before deciding: Take with adequate fluid and separate from medicines because absorption can change.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective

ConstipationAbout 5 g once or twice daily, titrated

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

LDL cholesterolAbout 7–10 g/day soluble psyllium is commonly studied

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat/water classification is not the key factor

Fat/water solubility is not the useful decision point; preparation, fluid, timing, or strain identity matters more.

How it is commonly taken

Mix each dose with at least 240 mL water and drink promptly.

Do not combine casually

Separate medicines by about 2 hours; avoid with swallowing difficulty or bowel obstruction.

Dose and use source ↗

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

4research papers in this ledger

29unique primary studies represented

2,003unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2024

Supports a specific usePMID 38844885

The effect of psyllium on fasting blood sugar, HbA1c, HOMA-IR, and insulin control

Fasting glucose, HbA1c, and HOMA-IR improved, while insulin did not clearly change. Possible overlap with the lipid review means this publication is context-only.

Published: 2024

Study design and methods

Design: GRADE-assessed systematic review and meta-analysis of 19 randomized trials
Population: 962 adults across varied glycemic states
Intervention: Psyllium versus placebo; doses and durations varied
Outcome: Fasting glucose, HbA1c, HOMA-IR, and insulin

Funding or conflict note: The authors declared no competing interests.

Open research record ↗

2021

Mixed or qualifiedPMID 34074830

Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes

All three approaches improved bowel-movement frequency; adverse events were most common with psyllium.

Published: 2021Duration: 4 weeksn=79 participants

Study design and methods

Design: Partially randomized comparative effectiveness trial
Population: 79 U.S. adults with chronic constipation
Intervention: 12 g psyllium daily versus two kiwifruit or 100 g prunes daily
Outcome: Complete spontaneous bowel movements, symptoms, satisfaction, and adverse events

Open research record ↗

2018

Supports a specific usePMID 30239559

Effect of psyllium fiber on LDL cholesterol and alternative lipid targets

Psyllium reduced LDL by about 0.33 mmol/L and also improved non-HDL cholesterol and apoB.

Published: 2018n=1,924 participants28 primary studies represented

Study design and methods

Design: Systematic review and meta-analysis of randomized trials
Population: 1,924 adults across 28 trials, with or without high cholesterol
Intervention: Median 10.2 g psyllium daily for at least 3 weeks
Outcome: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B

Open research record ↗

2018

Safety signalPMID 30321826

Intestinal obstruction caused by psyllium

Psyllium can swell and obstruct the gastrointestinal tract when fluid is inadequate or obstruction risk is already present. This case is not included in efficacy totals.

Published: 2018

Study design and methods

Design: Case report and literature review
Population: A young adult with constipation who took psyllium without enough fluid
Intervention: Granular psyllium with inadequate fluid
Outcome: Intestinal obstruction

Open research record ↗

Unscreened discovery appendix—not evidence266 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewNIH Office of Dietary Supplements directory Live PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.